A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
Clinical trial NCT05481307 · COMPLETED
Trial details
- NCT number
- NCT05481307
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2022-10-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.